MediciNova, Inc. (MNOV) Social Stream
MEDICINOVA INC (MNOV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MNOV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 3 | $27 | $10 | $16.5 | $1.53 | 978.43% |
| 2022-03-01 | 3 | $27 | $6 | $14.333 | $1.53 | 836.8% |
| 2022-04-06 | 1 | $27 | $6 | $14.333 | $1.53 | 836.8% |
| 2022-08-19 | 2 | $27 | $6 | $13 | $1.53 | 749.67% |
| 2023-02-27 | 3 | $27 | $6 | $13 | $1.53 | 749.67% |
| 2023-05-30 | 2 | $27 | $6 | $16.5 | $1.53 | 978.43% |
| 2023-08-21 | 1 | $26 | $6 | $16 | $1.53 | 945.75% |
| 2023-11-27 | 1 | $27 | $6 | $16.5 | $1.53 | 978.43% |
Price Target Last Issued August 21, 2023
The Trend in the Analyst Price Target
Over the past 24 months, MNOV's average price target has gone up $10.5.
Over the past 39 weeks, MNOV's average upside potential has been 703%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-27 | 2 | 27 | 6 | 16.5 | 2.21 | 646.61% |
| 2023-02-27 | 2 | 27 | 6 | 13.0 | 2.21 | 488.24% |
| 2023-05-30 | 2 | 27 | 6 | 16.5 | 2.14 | 671.03% |
| 2023-08-21 | 2 | 26 | 6 | 16.0 | 2.36 | 577.97% |
| 2023-11-27 | 1 | 27 | 27 | 27.0 | 1.78 | 1416.85% |
MNOV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 36 months, MNOV's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, MEDICINOVA INC's upside potential (average analyst target price relative to current price) is greater than 1260.07% of them.
- In terms of how MEDICINOVA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 40.84% of that group.
- To contextualize these metrics, consider that out of all US stocks, MEDICINOVA INC's variance in analysts' estimates is lower than -1031.37% of them.
- MNOV has a higher average analyst price target than 363.84% of Healthcare stocks.
In the Pharmaceutical Products industry, SVRA, BPTH, and ONTX are the three stocks most similar to MEDICINOVA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding MNOV using the data that counts. Try POWR Ratings for free.